Document Detail


Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
MedLine Citation:
PMID:  8235924     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVES: Cefotaxime is a third-generation cephalosporin that has in vitro activity against Neisseria gonorrhoeae, including beta-lactamase-producing strains. A single 1-g intramuscular dose is effective and is recommended by the Centers for Disease Control and Prevention as an alternative treatment for uncomplicated gonorrhea. GOAL OF THIS STUDY: This study was conducted to evaluate the efficacy and safety of a lower 500-mg dose of cefotaxime in the treatment of uncomplicated gonococcal infections. STUDY DESIGN: In a randomized multicenter study, patients who had uncomplicated gonorrhea were treated with 500 mg of cefotaxime or 250 mg of ceftriaxone. Both antibiotics were given intramuscularly. Efficacy and safety were assessed four to seven days following treatment. RESULTS: Six hundred thirteen patients were enrolled. Bacteriologic eradication rates for anogenital infection were 97.7% of the patients (213/218) in the cefotaxime group and 99.1% of the patients (221/223) in the ceftriaxone group (P = 0.243). Adverse events occurred in 4.2% and 7.5% of patients in the two groups, respectively. CONCLUSION: Cefotaxime 500 mg appears to be a safe and cost-effective alternative to ceftriaxone 250 mg for the treatment of uncomplicated gonorrhea.
Authors:
W M McCormack; W J Mogabgab; R B Jones; E W Hook; G D Wendel; H H Handsfield
Related Documents :
3835164 - A comparison of three different prophylactic parenteral antibiotic regimens in colorect...
2060524 - Treatment of acute toxoplasmosis with oral clindamycin.
18491964 - Comparison of clinical and microbiological response to treatment of clostridium diffici...
15813834 - Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial...
24516984 - Changes in soft tissue profile following the treatment using a herbst appliance--a phot...
484914 - Experience with a noninvasive evaluation for cerebral vascular disease.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Sexually transmitted diseases     Volume:  20     ISSN:  0148-5717     ISO Abbreviation:  Sex Transm Dis     Publication Date:    1993 Sep-Oct
Date Detail:
Created Date:  1993-12-01     Completed Date:  1993-12-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7705941     Medline TA:  Sex Transm Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  269-73     Citation Subset:  IM    
Affiliation:
State University of New York, Health Science Center, Brooklyn 11203.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cefotaxime / adverse effects,  pharmacology,  therapeutic use*
Ceftriaxone / adverse effects,  pharmacology,  therapeutic use*
Female
Gonorrhea / drug therapy*
Humans
Injections, Intramuscular
Male
Microbial Sensitivity Tests
Neisseria gonorrhoeae / drug effects*
Penicillins / pharmacology
Tetracycline / pharmacology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Penicillins; 60-54-8/Tetracycline; 63527-52-6/Cefotaxime; 73384-59-5/Ceftriaxone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vaginal infections in diabetic women: is empiric antifungal therapy appropriate?
Next Document:  Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.